▶ 調査レポート

世界の遺伝性疾患診断市場規模・現状・予測(2021年-2027年)

• 英文タイトル:Global Genetic Disease Diagnostic Market Size, Status and Forecast 2021-2027

QYResearchが調査・発行した産業分析レポートです。世界の遺伝性疾患診断市場規模・現状・予測(2021年-2027年) / Global Genetic Disease Diagnostic Market Size, Status and Forecast 2021-2027 / QYR2104Z2535資料のイメージです。• レポートコード:QYR2104Z2535
• 出版社/出版日:QYResearch / 2021年4月
※2025年版があります。お問い合わせください。

• レポート形態:英文、PDF、90ページ
• 納品方法:Eメール(納期:3日)
• 産業分類:医療
• 販売価格(消費税別)
  Single User¥546,000 (USD3,900)▷ お問い合わせ
  Multi User/Five User¥819,000 (USD5,850)▷ お問い合わせ
  Enterprise License(同一法人内共有可)¥1,092,000 (USD7,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
QYResearch社発行の本調査資料では、遺伝性疾患診断のグローバル市場(2016年~2027年)について調べ、市場動向、主要企業の市場シェア、種類別市場規模(出生前診断、遺伝子治療)、用途別市場規模(遺伝性疾患検査、薬理遺伝学的検査(PGx)、ヒト白血球抗原(HLA)検査、腫瘍学検査)、主要地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、関連企業情報などを掲載しています。
・市場概要
・遺伝性疾患診断の市場動向
・企業の競争状況、市場シェア
・遺伝性疾患診断の種類別市場規模(出生前診断、遺伝子治療)
・遺伝性疾患診断の用途別市場規模(遺伝性疾患検査、薬理遺伝学的検査(PGx)、ヒト白血球抗原(HLA)検査、腫瘍学検査)
・遺伝性疾患診断の北米市場規模2016-2027(アメリカ、カナダ)
・遺伝性疾患診断のヨーロッパ市場規模2016-2027(ドイツ、フランス、イギリス等)
・遺伝性疾患診断のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・遺伝性疾患診断の中南米市場規模2016-2027(メキシコ、ブラジル)
・遺伝性疾患診断の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(Abbott、Celera Group、Elitech Group、PerkinElmer、Quest Diagnostics、AutoGenomics、Roche Diagnostics、BioRad、Transgenomic、Applied Biosystems)
・結論

Market Analysis and Insights: Global Genetic Disease Diagnostic Market
The global Genetic Disease Diagnostic market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Genetic Disease Diagnostic market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Genetic Disease Diagnostic market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Genetic Disease Diagnostic market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Genetic Disease Diagnostic market.

Global Genetic Disease Diagnostic Scope and Market Size
Genetic Disease Diagnostic market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Genetic Disease Diagnostic market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Prenatal diagnosis
Gene therapy

Segment by Application
Inherited disorder testing
Pharmacogenetic testing (PGx)
Human leukocyte antigen (HLA) testing
Oncology testing

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Abbott
Celera Group
Elitech Group
PerkinElmer
Quest Diagnostics
AutoGenomics
Roche Diagnostics
BioRad
Transgenomic

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Genetic Disease Diagnostic Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Prenatal diagnosis
1.2.3 Gene therapy
1.3 Market by Application
1.3.1 Global Genetic Disease Diagnostic Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Inherited disorder testing
1.3.3 Pharmacogenetic testing (PGx)
1.3.4 Human leukocyte antigen (HLA) testing
1.3.5 Oncology testing
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Genetic Disease Diagnostic Market Perspective (2016-2027)
2.2 Genetic Disease Diagnostic Growth Trends by Regions
2.2.1 Genetic Disease Diagnostic Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Genetic Disease Diagnostic Historic Market Share by Regions (2016-2021)
2.2.3 Genetic Disease Diagnostic Forecasted Market Size by Regions (2022-2027)
2.3 Genetic Disease Diagnostic Industry Dynamic
2.3.1 Genetic Disease Diagnostic Market Trends
2.3.2 Genetic Disease Diagnostic Market Drivers
2.3.3 Genetic Disease Diagnostic Market Challenges
2.3.4 Genetic Disease Diagnostic Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Genetic Disease Diagnostic Players by Revenue
3.1.1 Global Top Genetic Disease Diagnostic Players by Revenue (2016-2021)
3.1.2 Global Genetic Disease Diagnostic Revenue Market Share by Players (2016-2021)
3.2 Global Genetic Disease Diagnostic Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Genetic Disease Diagnostic Revenue
3.4 Global Genetic Disease Diagnostic Market Concentration Ratio
3.4.1 Global Genetic Disease Diagnostic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Genetic Disease Diagnostic Revenue in 2020
3.5 Genetic Disease Diagnostic Key Players Head office and Area Served
3.6 Key Players Genetic Disease Diagnostic Product Solution and Service
3.7 Date of Enter into Genetic Disease Diagnostic Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Genetic Disease Diagnostic Breakdown Data by Type
4.1 Global Genetic Disease Diagnostic Historic Market Size by Type (2016-2021)
4.2 Global Genetic Disease Diagnostic Forecasted Market Size by Type (2022-2027)

5 Genetic Disease Diagnostic Breakdown Data by Application
5.1 Global Genetic Disease Diagnostic Historic Market Size by Application (2016-2021)
5.2 Global Genetic Disease Diagnostic Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Genetic Disease Diagnostic Market Size (2016-2027)
6.2 North America Genetic Disease Diagnostic Market Size by Type
6.2.1 North America Genetic Disease Diagnostic Market Size by Type (2016-2021)
6.2.2 North America Genetic Disease Diagnostic Market Size by Type (2022-2027)
6.2.3 North America Genetic Disease Diagnostic Market Size by Type (2016-2027)
6.3 North America Genetic Disease Diagnostic Market Size by Application
6.3.1 North America Genetic Disease Diagnostic Market Size by Application (2016-2021)
6.3.2 North America Genetic Disease Diagnostic Market Size by Application (2022-2027)
6.3.3 North America Genetic Disease Diagnostic Market Size by Application (2016-2027)
6.4 North America Genetic Disease Diagnostic Market Size by Country
6.4.1 North America Genetic Disease Diagnostic Market Size by Country (2016-2021)
6.4.2 North America Genetic Disease Diagnostic Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Genetic Disease Diagnostic Market Size (2016-2027)
7.2 Europe Genetic Disease Diagnostic Market Size by Type
7.2.1 Europe Genetic Disease Diagnostic Market Size by Type (2016-2021)
7.2.2 Europe Genetic Disease Diagnostic Market Size by Type (2022-2027)
7.2.3 Europe Genetic Disease Diagnostic Market Size by Type (2016-2027)
7.3 Europe Genetic Disease Diagnostic Market Size by Application
7.3.1 Europe Genetic Disease Diagnostic Market Size by Application (2016-2021)
7.3.2 Europe Genetic Disease Diagnostic Market Size by Application (2022-2027)
7.3.3 Europe Genetic Disease Diagnostic Market Size by Application (2016-2027)
7.4 Europe Genetic Disease Diagnostic Market Size by Country
7.4.1 Europe Genetic Disease Diagnostic Market Size by Country (2016-2021)
7.4.2 Europe Genetic Disease Diagnostic Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Genetic Disease Diagnostic Market Size (2016-2027)
8.2 Asia-Pacific Genetic Disease Diagnostic Market Size by Type
8.2.1 Asia-Pacific Genetic Disease Diagnostic Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Genetic Disease Diagnostic Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Genetic Disease Diagnostic Market Size by Type (2016-2027)
8.3 Asia-Pacific Genetic Disease Diagnostic Market Size by Application
8.3.1 Asia-Pacific Genetic Disease Diagnostic Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Genetic Disease Diagnostic Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Genetic Disease Diagnostic Market Size by Application (2016-2027)
8.4 Asia-Pacific Genetic Disease Diagnostic Market Size by Region
8.4.1 Asia-Pacific Genetic Disease Diagnostic Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Genetic Disease Diagnostic Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Genetic Disease Diagnostic Market Size (2016-2027)
9.2 Latin America Genetic Disease Diagnostic Market Size by Type
9.2.1 Latin America Genetic Disease Diagnostic Market Size by Type (2016-2021)
9.2.2 Latin America Genetic Disease Diagnostic Market Size by Type (2022-2027)
9.2.3 Latin America Genetic Disease Diagnostic Market Size by Type (2016-2027)
9.3 Latin America Genetic Disease Diagnostic Market Size by Application
9.3.1 Latin America Genetic Disease Diagnostic Market Size by Application (2016-2021)
9.3.2 Latin America Genetic Disease Diagnostic Market Size by Application (2022-2027)
9.3.3 Latin America Genetic Disease Diagnostic Market Size by Application (2016-2027)
9.4 Latin America Genetic Disease Diagnostic Market Size by Country
9.4.1 Latin America Genetic Disease Diagnostic Market Size by Country (2016-2021)
9.4.2 Latin America Genetic Disease Diagnostic Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Genetic Disease Diagnostic Market Size (2016-2027)
10.2 Middle East & Africa Genetic Disease Diagnostic Market Size by Type
10.2.1 Middle East & Africa Genetic Disease Diagnostic Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Genetic Disease Diagnostic Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Genetic Disease Diagnostic Market Size by Type (2016-2027)
10.3 Middle East & Africa Genetic Disease Diagnostic Market Size by Application
10.3.1 Middle East & Africa Genetic Disease Diagnostic Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Genetic Disease Diagnostic Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Genetic Disease Diagnostic Market Size by Application (2016-2027)
10.4 Middle East & Africa Genetic Disease Diagnostic Market Size by Country
10.4.1 Middle East & Africa Genetic Disease Diagnostic Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Genetic Disease Diagnostic Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Details
11.1.2 Abbott Business Overview
11.1.3 Abbott Genetic Disease Diagnostic Introduction
11.1.4 Abbott Revenue in Genetic Disease Diagnostic Business (2016-2021)
11.1.5 Abbott Recent Development
11.2 Celera Group
11.2.1 Celera Group Company Details
11.2.2 Celera Group Business Overview
11.2.3 Celera Group Genetic Disease Diagnostic Introduction
11.2.4 Celera Group Revenue in Genetic Disease Diagnostic Business (2016-2021)
11.2.5 Celera Group Recent Development
11.3 Elitech Group
11.3.1 Elitech Group Company Details
11.3.2 Elitech Group Business Overview
11.3.3 Elitech Group Genetic Disease Diagnostic Introduction
11.3.4 Elitech Group Revenue in Genetic Disease Diagnostic Business (2016-2021)
11.3.5 Elitech Group Recent Development
11.4 PerkinElmer
11.4.1 PerkinElmer Company Details
11.4.2 PerkinElmer Business Overview
11.4.3 PerkinElmer Genetic Disease Diagnostic Introduction
11.4.4 PerkinElmer Revenue in Genetic Disease Diagnostic Business (2016-2021)
11.4.5 PerkinElmer Recent Development
11.5 Quest Diagnostics
11.5.1 Quest Diagnostics Company Details
11.5.2 Quest Diagnostics Business Overview
11.5.3 Quest Diagnostics Genetic Disease Diagnostic Introduction
11.5.4 Quest Diagnostics Revenue in Genetic Disease Diagnostic Business (2016-2021)
11.5.5 Quest Diagnostics Recent Development
11.6 AutoGenomics
11.6.1 AutoGenomics Company Details
11.6.2 AutoGenomics Business Overview
11.6.3 AutoGenomics Genetic Disease Diagnostic Introduction
11.6.4 AutoGenomics Revenue in Genetic Disease Diagnostic Business (2016-2021)
11.6.5 AutoGenomics Recent Development
11.7 Roche Diagnostics
11.7.1 Roche Diagnostics Company Details
11.7.2 Roche Diagnostics Business Overview
11.7.3 Roche Diagnostics Genetic Disease Diagnostic Introduction
11.7.4 Roche Diagnostics Revenue in Genetic Disease Diagnostic Business (2016-2021)
11.7.5 Roche Diagnostics Recent Development
11.8 BioRad
11.8.1 BioRad Company Details
11.8.2 BioRad Business Overview
11.8.3 BioRad Genetic Disease Diagnostic Introduction
11.8.4 BioRad Revenue in Genetic Disease Diagnostic Business (2016-2021)
11.8.5 BioRad Recent Development
11.9 Transgenomic
11.9.1 Transgenomic Company Details
11.9.2 Transgenomic Business Overview
11.9.3 Transgenomic Genetic Disease Diagnostic Introduction
11.9.4 Transgenomic Revenue in Genetic Disease Diagnostic Business (2016-2021)
11.9.5 Transgenomic Recent Development
11.10 Applied Biosystems
11.10.1 Applied Biosystems Company Details
11.10.2 Applied Biosystems Business Overview
11.10.3 Applied Biosystems Genetic Disease Diagnostic Introduction
11.10.4 Applied Biosystems Revenue in Genetic Disease Diagnostic Business (2016-2021)
11.10.5 Applied Biosystems Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Genetic Disease Diagnostic Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Prenatal diagnosis
Table 3. Key Players of Gene therapy
Table 4. Global Genetic Disease Diagnostic Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Genetic Disease Diagnostic Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Genetic Disease Diagnostic Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Genetic Disease Diagnostic Market Share by Regions (2016-2021)
Table 8. Global Genetic Disease Diagnostic Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Genetic Disease Diagnostic Market Share by Regions (2022-2027)
Table 10. Genetic Disease Diagnostic Market Trends
Table 11. Genetic Disease Diagnostic Market Drivers
Table 12. Genetic Disease Diagnostic Market Challenges
Table 13. Genetic Disease Diagnostic Market Restraints
Table 14. Global Genetic Disease Diagnostic Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Genetic Disease Diagnostic Market Share by Players (2016-2021)
Table 16. Global Top Genetic Disease Diagnostic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Genetic Disease Diagnostic as of 2020)
Table 17. Ranking of Global Top Genetic Disease Diagnostic Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Genetic Disease Diagnostic Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Genetic Disease Diagnostic Product Solution and Service
Table 21. Date of Enter into Genetic Disease Diagnostic Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Genetic Disease Diagnostic Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Genetic Disease Diagnostic Revenue Market Share by Type (2016-2021)
Table 25. Global Genetic Disease Diagnostic Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Genetic Disease Diagnostic Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Genetic Disease Diagnostic Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Genetic Disease Diagnostic Revenue Market Share by Application (2016-2021)
Table 29. Global Genetic Disease Diagnostic Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Genetic Disease Diagnostic Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Genetic Disease Diagnostic Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Genetic Disease Diagnostic Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Genetic Disease Diagnostic Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Genetic Disease Diagnostic Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Genetic Disease Diagnostic Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Genetic Disease Diagnostic Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Genetic Disease Diagnostic Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Genetic Disease Diagnostic Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Genetic Disease Diagnostic Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Genetic Disease Diagnostic Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Genetic Disease Diagnostic Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Genetic Disease Diagnostic Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Genetic Disease Diagnostic Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Genetic Disease Diagnostic Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Genetic Disease Diagnostic Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Genetic Disease Diagnostic Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Genetic Disease Diagnostic Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Genetic Disease Diagnostic Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Genetic Disease Diagnostic Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Genetic Disease Diagnostic Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Genetic Disease Diagnostic Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Genetic Disease Diagnostic Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Genetic Disease Diagnostic Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Genetic Disease Diagnostic Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Genetic Disease Diagnostic Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Genetic Disease Diagnostic Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Genetic Disease Diagnostic Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Genetic Disease Diagnostic Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Genetic Disease Diagnostic Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Genetic Disease Diagnostic Market Size by Country (2022-2027) & (US$ Million)
Table 61. Abbott Company Details
Table 62. Abbott Business Overview
Table 63. Abbott Genetic Disease Diagnostic Product
Table 64. Abbott Revenue in Genetic Disease Diagnostic Business (2016-2021) & (US$ Million)
Table 65. Abbott Recent Development
Table 66. Celera Group Company Details
Table 67. Celera Group Business Overview
Table 68. Celera Group Genetic Disease Diagnostic Product
Table 69. Celera Group Revenue in Genetic Disease Diagnostic Business (2016-2021) & (US$ Million)
Table 70. Celera Group Recent Development
Table 71. Elitech Group Company Details
Table 72. Elitech Group Business Overview
Table 73. Elitech Group Genetic Disease Diagnostic Product
Table 74. Elitech Group Revenue in Genetic Disease Diagnostic Business (2016-2021) & (US$ Million)
Table 75. Elitech Group Recent Development
Table 76. PerkinElmer Company Details
Table 77. PerkinElmer Business Overview
Table 78. PerkinElmer Genetic Disease Diagnostic Product
Table 79. PerkinElmer Revenue in Genetic Disease Diagnostic Business (2016-2021) & (US$ Million)
Table 80. PerkinElmer Recent Development
Table 81. Quest Diagnostics Company Details
Table 82. Quest Diagnostics Business Overview
Table 83. Quest Diagnostics Genetic Disease Diagnostic Product
Table 84. Quest Diagnostics Revenue in Genetic Disease Diagnostic Business (2016-2021) & (US$ Million)
Table 85. Quest Diagnostics Recent Development
Table 86. AutoGenomics Company Details
Table 87. AutoGenomics Business Overview
Table 88. AutoGenomics Genetic Disease Diagnostic Product
Table 89. AutoGenomics Revenue in Genetic Disease Diagnostic Business (2016-2021) & (US$ Million)
Table 90. AutoGenomics Recent Development
Table 91. Roche Diagnostics Company Details
Table 92. Roche Diagnostics Business Overview
Table 93. Roche Diagnostics Genetic Disease Diagnostic Product
Table 94. Roche Diagnostics Revenue in Genetic Disease Diagnostic Business (2016-2021) & (US$ Million)
Table 95. Roche Diagnostics Recent Development
Table 96. BioRad Company Details
Table 97. BioRad Business Overview
Table 98. BioRad Revenue in Genetic Disease Diagnostic Business (2016-2021) & (US$ Million)
Table 99. BioRad Recent Development
Table 100. Transgenomic Company Details
Table 101. Transgenomic Business Overview
Table 102. Transgenomic Genetic Disease Diagnostic Product
Table 103. Transgenomic Revenue in Genetic Disease Diagnostic Business (2016-2021) & (US$ Million)
Table 104. Transgenomic Recent Development
Table 105. Applied Biosystems Company Details
Table 106. Applied Biosystems Business Overview
Table 107. Applied Biosystems Genetic Disease Diagnostic Product
Table 108. Applied Biosystems Revenue in Genetic Disease Diagnostic Business (2016-2021) & (US$ Million)
Table 109. Applied Biosystems Recent Development
Table 110. Research Programs/Design for This Report
Table 111. Key Data Information from Secondary Sources
Table 112. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Genetic Disease Diagnostic Market Share by Type: 2020 VS 2027
Figure 2. Prenatal diagnosis Features
Figure 3. Gene therapy Features
Figure 4. Global Genetic Disease Diagnostic Market Share by Application: 2020 VS 2027
Figure 5. Inherited disorder testing Case Studies
Figure 6. Pharmacogenetic testing (PGx) Case Studies
Figure 7. Human leukocyte antigen (HLA) testing Case Studies
Figure 8. Oncology testing Case Studies
Figure 9. Genetic Disease Diagnostic Report Years Considered
Figure 10. Global Genetic Disease Diagnostic Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Genetic Disease Diagnostic Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Genetic Disease Diagnostic Market Share by Regions: 2020 VS 2027
Figure 13. Global Genetic Disease Diagnostic Market Share by Regions (2022-2027)
Figure 14. Global Genetic Disease Diagnostic Market Share by Players in 2020
Figure 15. Global Top Genetic Disease Diagnostic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Genetic Disease Diagnostic as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Genetic Disease Diagnostic Revenue in 2020
Figure 17. Global Genetic Disease Diagnostic Revenue Market Share by Type (2016-2021)
Figure 18. Global Genetic Disease Diagnostic Revenue Market Share by Type (2022-2027)
Figure 19. North America Genetic Disease Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Genetic Disease Diagnostic Market Share by Type (2016-2027)
Figure 21. North America Genetic Disease Diagnostic Market Share by Application (2016-2027)
Figure 22. North America Genetic Disease Diagnostic Market Share by Country (2016-2027)
Figure 23. United States Genetic Disease Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Genetic Disease Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Genetic Disease Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Genetic Disease Diagnostic Market Share by Type (2016-2027)
Figure 27. Europe Genetic Disease Diagnostic Market Share by Application (2016-2027)
Figure 28. Europe Genetic Disease Diagnostic Market Share by Country (2016-2027)
Figure 29. Germany Genetic Disease Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Genetic Disease Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Genetic Disease Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Genetic Disease Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Genetic Disease Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Genetic Disease Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Genetic Disease Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Genetic Disease Diagnostic Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Genetic Disease Diagnostic Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Genetic Disease Diagnostic Market Share by Region (2016-2027)
Figure 39. China Genetic Disease Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Genetic Disease Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Genetic Disease Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Genetic Disease Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Genetic Disease Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Genetic Disease Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Genetic Disease Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Genetic Disease Diagnostic Market Share by Type (2016-2027)
Figure 47. Latin America Genetic Disease Diagnostic Market Share by Application (2016-2027)
Figure 48. Latin America Genetic Disease Diagnostic Market Share by Country (2016-2027)
Figure 49. Mexico Genetic Disease Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Genetic Disease Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Genetic Disease Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Genetic Disease Diagnostic Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Genetic Disease Diagnostic Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Genetic Disease Diagnostic Market Share by Country (2016-2027)
Figure 55. Turkey Genetic Disease Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Genetic Disease Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Genetic Disease Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Abbott Revenue Growth Rate in Genetic Disease Diagnostic Business (2016-2021)
Figure 59. Celera Group Revenue Growth Rate in Genetic Disease Diagnostic Business (2016-2021)
Figure 60. Elitech Group Revenue Growth Rate in Genetic Disease Diagnostic Business (2016-2021)
Figure 61. PerkinElmer Revenue Growth Rate in Genetic Disease Diagnostic Business (2016-2021)
Figure 62. Quest Diagnostics Revenue Growth Rate in Genetic Disease Diagnostic Business (2016-2021)
Figure 63. AutoGenomics Revenue Growth Rate in Genetic Disease Diagnostic Business (2016-2021)
Figure 64. Roche Diagnostics Revenue Growth Rate in Genetic Disease Diagnostic Business (2016-2021)
Figure 65. BioRad Revenue Growth Rate in Genetic Disease Diagnostic Business (2016-2021)
Figure 66. Transgenomic Revenue Growth Rate in Genetic Disease Diagnostic Business (2016-2021)
Figure 67. Applied Biosystems Revenue Growth Rate in Genetic Disease Diagnostic Business (2016-2021)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed